CG
PACB icon

Cutler Group’s Pacific Biosciences PACB Stock Holding History

Cutler Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,000
Closed -$2K – 3228
2023
Q4 		$2K Buy
1,000
+600
+150% +$4.91K ﹤0.01% 3154
2023
Q3 		$1K Hold
400
– – ﹤0.01% 3590
2023
Q2 		$3K Sell
400
-5,100
-93% -$62K ﹤0.01% 2884
2023
Q1 		$16K Sell
5,500
-1,400
-20% -$13.9K ﹤0.01% 2047
2022
Q4 		$5K Sell
6,900
-45,300
-87% -$390K ﹤0.01% 3199
2022
Q3 		$13K Sell
52,200
-26,700
-34% -$153K ﹤0.01% 2939
2022
Q2 		$12K Buy
78,900
+29,200
+59% +$177K ﹤0.01% 3061
2022
Q1 		$10K Buy
49,700
+37,300
+301% +$429K ﹤0.01% 3622
2021
Q4 		$8K Sell
12,400
-28,700
-70% -$693K ﹤0.01% 3876
2021
Q3 		$21K Buy
41,100
+21,100
+106% +$625K ﹤0.01% 3309
2021
Q2 		$113K Sell
20,000
-43,200
-68% -$1.26M 0.01% 1771
2021
Q1 		$80K Buy
63,200
+41,200
+187% +$1.44M ﹤0.01% 1959
2020
Q4 		$56K Buy
+22,000
New +$374K ﹤0.01% 1931
2017
Q2 		– Sell
-13,000
Closed -$10K – 6872
2017
Q1 		$10K Buy
+13,000
New +$63.6K ﹤0.01% 4048
2016
Q4 		– Sell
-96,200
Closed -$38K – 7098
2016
Q3 		$38K Sell
96,200
-30,100
-24% -$252K ﹤0.01% 2727
2016
Q2 		$45K Buy
126,300
+10,400
+9% +$95K ﹤0.01% 2465
2016
Q1 		$73K Buy
115,900
+108,500
+1,466% +$1.07M ﹤0.01% 1920
2015
Q4 		$60K Buy
+7,400
New +$66.4K ﹤0.01% 2271

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Cutler Group's PACB Position: Q4 2023 in Review

Cutler Group sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 10,620 shares — an estimated $86.9K sold.

Cutler Group first reported a position in PACB in Q4 2015 and held it in 18 quarters. The position peaked at $1.28M in Q1 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Cutler Group reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 10,620 Pacific Biosciences shares in Q4 2023, an estimated $86.9K.
  • Cutler Group first reported a position in Pacific Biosciences in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Pacific Biosciences position peaked at $1.28M in Q1 2021.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.